<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Capillary malformations (port wine birthmarks) and associated syndromes
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Capillary malformations (port wine birthmarks) and associated syndromes
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Capillary malformations (port wine birthmarks) and associated syndromes
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sheila Galbraith, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Moise L Levy, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Rosamaria Corona, MD, DSc
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Sep 05, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H31576694">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Capillary malformations (also called port wine birthmarks or nevus flammeus, MIM #163000) are congenital low-flow vascular malformations of dermal capillaries and postcapillary venules. They are most often isolated skin anomalies but may rarely occur as part of complex malformation syndromes. (See
         <a class="local">
          'Associated syndromes'
         </a>
         below.)
        </p>
        <p>
         Capillary malformations are present at birth as blanchable, pink to red patches and may be located anywhere on the body, typically with a unilateral or segmental distribution that respects the midline. They should not be confused with infantile hemangiomas, common vascular tumors of infancy that only in a minority of cases are present at birth. In contrast with infantile hemangiomas, capillary malformations do not regress with time but grow in proportion to the child's growth and become thicker and darker in color during adulthood. (See
         <a class="medical medical_review" href="/z/d/html/5794.html" rel="external">
          "Infantile hemangiomas: Epidemiology, pathogenesis, clinical features, and complications"
         </a>
         .)
        </p>
        <p>
         The pathogenesis, clinical presentation, and associated syndromes of capillary malformations will be discussed here. Laser treatment of capillary malformations is discussed separately. An overview of vascular lesions in newborns and venous malformations are also discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/13638.html" rel="external">
          "Laser and light therapy for cutaneous vascular lesions", section on 'Capillary malformations (port wine birthmarks)'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5789.html" rel="external">
          "Vascular lesions in the newborn"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/110155.html" rel="external">
          "Venous malformations"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1172065">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         In a prospective study and literature review, capillary malformations occurred in 0.1 to 2 percent of newborns without sex predilection [
         <a href="#rid1">
          1
         </a>
         ]. They are generally sporadic, but familial cases have been reported [
         <a href="#rid2">
          2-4
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H962310">
         <span class="h1">
          PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The etiology and pathogenesis of capillary malformations are unknown. Several mechanisms may be involved in their development, including vascular ectasia, lack of neuronal control of blood flow, overexpression of vascular endothelial growth factor (VEGF) and VEGF receptor, and development of compensatory, collateral passageways for venous drainage [
         <a href="#rid5">
          5-7
         </a>
         ].
        </p>
        <p>
         In a genome-wide study, a specific somatic mosaic activating mutation in the
         <em>
          GNAQ
         </em>
         gene on chromosome 9q21,2, encoding the guanine nucleotide binding protein G-alpha-q, was found in skin samples of 12 of 13 participants with nonsyndromic port wine birthmarks and in skin or brain samples of 23 of 26 participants with Sturge-Weber syndrome (a rare congenital disorder characterized by facial capillary malformation and capillary-venous malformations affecting the brain and eye) but in none of six control subjects [
         <a href="#rid8">
          8
         </a>
         ]. This mutation (c.548G→A, resulting in the p.Arg183Gln amino acid substitution) may be involved in abnormal cell proliferation through the activation of the extracellular signal-regulated kinase (ERK) pathway. (See
         <a class="medical medical_review" href="/z/d/html/6159.html" rel="external">
          "Sturge-Weber syndrome"
         </a>
         .)
        </p>
        <p>
         Nonsyndromic port wine birthmarks may represent a late origin of the somatic
         <em>
          GNAQ
         </em>
         mutation in vascular endothelial cells, whereas in Sturge-Weber syndrome mutation may occur earlier during embryogenesis in progenitor cells that are precursors to a larger variety of cell types and tissues, leading to the syndromic phenotype.
        </p>
        <p>
         Inactivating mutations in the
         <em>
          RASA1
         </em>
         gene, which cause the autosomal dominant capillary malformation-arteriovenous malformation syndrome, may be involved in hereditary cases of capillary malformations without arteriovenous malformations [
         <a href="#rid2">
          2,9
         </a>
         ]. The
         <em>
          RAS
         </em>
         gene family encodes membrane-associated proteins that are involved in the control of cell proliferation and differentiation and organization of endothelial cells into highly organized networks [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H435476">
         <span class="h1">
          PATHOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Histologic examination of port wine birthmarks reveals ectatic capillaries and postcapillary venules in the papillary and reticular dermis. The number of vessels is not increased and there is no endothelial proliferation. Later-stage lesions develop progressive fibrosis around the vessels and dilatation of the channels. Decreased nerve density has been demonstrated within affected areas [
         <a href="#rid5">
          5,11
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H31576703">
         <span class="h1">
          CLINICAL FEATURES
         </span>
        </p>
        <p class="headingAnchor" id="H89685844">
         <span class="h2">
          Clinical presentation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Capillary malformations are present at birth as partially or completely blanchable, pink to red or reddish-brown patches, with unilateral or segmental distribution that respects the midline  (
         <a class="graphic graphic_picture graphicRef59124" href="/z/d/graphic/59124.html" rel="external">
          picture 5B
         </a>
         ). Lesions are flat, painless, and the same temperature as surrounding skin.
        </p>
        <p>
         The face is a common location, but capillary malformations can occur anywhere on the body  (
         <a class="graphic graphic_picture graphicRef54078" href="/z/d/graphic/54078.html" rel="external">
          picture 1
         </a>
         ). On the face, they tend to follow the distribution of the trigeminal nerve branches (segments V1 [ophthalmic], V2 [maxillary], and V3 [mandibular])  (
         <a class="graphic graphic_picture graphicRef73978" href="/z/d/graphic/73978.html" rel="external">
          picture 5C
         </a>
         and
         <a class="graphic graphic_figure graphicRef52850" href="/z/d/graphic/52850.html" rel="external">
          figure 1
         </a>
         ). It has also been suggested that the pattern of capillary malformations may correspond to areas of somatic mosaicism or follow the embryonic vasculature [
         <a href="#rid12">
          12,13
         </a>
         ]. Facial lesions may extend into the mucosal surfaces of the lips and gingivae.
        </p>
        <p>
         In most cases, capillary malformations are isolated cutaneous anomalies. However, they may be associated with other abnormalities (eg, glaucoma and occult spinal dysraphism) or be a component of complex malformation syndromes (eg, Sturge-Weber or Klippel Trenaunay syndrome). (See
         <a class="local">
          'Associated abnormalities/complications'
         </a>
         below and
         <a class="local">
          'Associated syndromes'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H802772">
         <span class="h2">
          Clinical course
         </span>
         <span class="headingEndMark">
          —
         </span>
         Capillary malformations do not regress over time but grow proportionally with the child's growth. Untreated lesions may become thicker, darker in color (port wine), and nodular in adulthood  (
         <a class="graphic graphic_picture graphicRef118757" href="/z/d/graphic/118757.html" rel="external">
          picture 2
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H830742">
         <span class="h2">
          Associated abnormalities/complications
         </span>
        </p>
        <p class="headingAnchor" id="H6789835">
         <span class="h3">
          Glaucoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         In a retrospective study of 216 children with periocular capillary malformations, 18 percent had glaucoma at presentation or developed glaucoma during a median follow-up of three years [
         <a href="#rid14">
          14
         </a>
         ]. Glaucoma was more common in patients with bilateral port wine birthmarks or involvement of the upper and lower eyelids (distribution areas of V1 and V2 trigeminal branches). A higher prevalence of glaucoma of 40 to 60 percent has been reported in case series of patients with facial capillary malformations associated with Sturge-Weber syndrome [
         <a href="#rid15">
          15,16
         </a>
         ]. Early-onset glaucoma occurs before age four and causes eye enlargement (buphthalmos), whereas late-onset glaucoma may be delayed until adolescence and is not associated with buphthalmos [
         <a href="#rid17">
          17
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6272.html" rel="external">
          "Overview of glaucoma in infants and children", section on 'Secondary glaucoma'
         </a>
         .)
        </p>
        <p>
         In patients with facial capillary malformation and glaucoma, brain imaging studies are recommended to exclude leptomeningeal involvement and Sturge-Weber syndrome. (See
         <a class="medical medical_review" href="/z/d/html/6159.html" rel="external">
          "Sturge-Weber syndrome", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H801764">
         <span class="h3">
          Occult spinal dysraphism
         </span>
         <span class="headingEndMark">
          —
         </span>
         The association between isolated capillary malformations located over the lumbar spine and spinal dysraphism is controversial [
         <a href="#rid18">
          18-21
         </a>
         ]. However, imaging studies to rule out occult spinal dysraphism are recommended when capillary malformations occur in conjunction with other cutaneous abnormalities (eg, hypertrichosis, dermal sinus or pit, lipomas, or deviated gluteal cleft) in the midline lumbosacral area. (See
         <a class="medical medical_review" href="/z/d/html/14405.html" rel="external">
          "Closed spinal dysraphism: Pathogenesis and types"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H6789856">
         <span class="h3">
          Soft tissue and bone overgrowth
         </span>
         <span class="headingEndMark">
          —
         </span>
         Soft tissue and/or bone overgrowth are complications of capillary malformations. Maxillary bone and gingival hyperplasia, lip enlargement, and abnormal bite may occur with facial capillary malformations in the V2 distribution [
         <a href="#rid22">
          22
         </a>
         ]. Overgrowth of digits or limbs also may occur with reticulated or extensive lesions localized to the limbs. [
         <a href="#rid23">
          23
         </a>
         ]
        </p>
        <p class="headingAnchor" id="H6789863">
         <span class="h3">
          Thickening and nodularity
         </span>
         <span class="headingEndMark">
          —
         </span>
         In large case series, skin thickening or "cobblestoning" with nodular growths within the capillary malformation occurs in up to 65 percent of lesions, especially within those located on the face  (
         <a class="graphic graphic_picture graphicRef58831" href="/z/d/graphic/58831.html" rel="external">
          picture 3
         </a>
         ) [
         <a href="#rid24">
          24-26
         </a>
         ]. On histologic examination, most nodules are pyogenic granulomas  (
         <a class="graphic graphic_picture graphicRef83687" href="/z/d/graphic/83687.html" rel="external">
          picture 4
         </a>
         ), arteriovenous malformations, or vascular ectasias [
         <a href="#rid27">
          27-31
         </a>
         ]. Easy bleeding within these lesions is common.
        </p>
        <p>
         Early treatment may prevent thickening and development of nodularity. (See
         <a class="medical medical_review" href="/z/d/html/13638.html" rel="external">
          "Laser and light therapy for cutaneous vascular lesions", section on 'Capillary malformations (port wine birthmarks)'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H89686176">
         <span class="h1">
          DIAGNOSIS
         </span>
        </p>
        <p class="headingAnchor" id="H89686219">
         <span class="h2">
          Clinical
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of capillary malformations is in most cases clinical and based upon the appearance, time of onset, and temporal evolution of the skin lesion:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In newborns and children, blanchable, pink to reddish patches, often with unilateral distribution and midline demarcation  (
         <a class="graphic graphic_picture graphicRef83601 graphicRef59124 graphicRef73978" href="/z/d/graphic/83601.html" rel="external">
          picture 5A-C
         </a>
         ); in adults, red to purple plaques with "cobblestoning" and nodular growths  (
         <a class="graphic graphic_picture graphicRef58831" href="/z/d/graphic/58831.html" rel="external">
          picture 3
         </a>
         ). Soft-tissue and bone overgrowth may be noted in children and adults. (See
         <a class="local">
          'Clinical features'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Presence at birth without regression over time.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Growth in proportion to body growth; hyperplastic changes of the skin and underlying tissues over time in untreated lesions. (See
         <a class="local">
          'Clinical course'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H89686226">
         <span class="h2">
          Imaging studies
         </span>
         <span class="headingEndMark">
          —
         </span>
         Imaging studies (ultrasonography or magnetic resonance) are not routinely performed in children with capillary malformations. However, imaging studies may be necessary in the evaluation of associated syndromes including:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In children with facial capillary malformation involving more than one trigeminal segment  (
         <a class="graphic graphic_figure graphicRef52850" href="/z/d/graphic/52850.html" rel="external">
          figure 1
         </a>
         ) or with neurologic symptoms and in those with facial capillary malformation and glaucoma, magnetic resonance imaging (MRI) of the brain is indicated to exclude Sturge-Weber [
         <a href="#rid17">
          17,32,33
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6159.html" rel="external">
          "Sturge-Weber syndrome", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In children with symptomatic capillary malformations (warm to the touch or painful), ultrasonography can identify venous varicosities associated with Klippel-Trenaunay syndrome (KTS) or exclude an associated fast-flow arteriovenous malformation. (See
         <a class="local">
          'Klippel-Trenaunay syndrome'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/13730.html" rel="external">
          "Klippel-Trenaunay syndrome: Clinical manifestations, diagnosis, and management"
         </a>
         and
         <a class="local">
          'Capillary malformation-arteriovenous malformation syndrome'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         MRI or computed tomography to exclude occult spinal dysraphism in children with midline lumbosacral capillary malformations associated with other cutaneous abnormalities (eg, hypertrichosis, dermal sinus or pit, lipomas, or deviated gluteal cleft). (See
         <a class="local">
          'Occult spinal dysraphism'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H89686233">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differential diagnosis of capillary malformations includes:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Nevus simplex
         </strong>
         – Nevus simplex, also called salmon patch or stork bite, is a common birthmark occurring in up to 80 percent of newborns [
         <a href="#rid1">
          1
         </a>
         ]. It is similar in appearance to capillary malformations but has more indistinct borders and is usually located in the midline. The most common locations are the glabella, upper eyelids, and nape of the neck  (
         <a class="graphic graphic_picture graphicRef110619" href="/z/d/graphic/110619.html" rel="external">
          picture 6
         </a>
         ), but they can also be present in other locations including the forehead  (
         <a class="graphic graphic_picture graphicRef83580" href="/z/d/graphic/83580.html" rel="external">
          picture 7
         </a>
         ), nose, upper and lower cutaneous lip, philtrum, scalp, and the upper, mid, and lower back [
         <a href="#rid34">
          34
         </a>
         ]. Unlike capillary malformations, these lesions (with the exception of those located on the nape of the neck) fade spontaneously over time. (See
         <a class="medical medical_review" href="/z/d/html/5789.html" rel="external">
          "Vascular lesions in the newborn", section on 'Nevus simplex (macular stain)'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Infantile hemangioma
         </strong>
         – In approximately one-third of cases, infantile hemangioma is present at birth as a macular telangiectatic patch similar in appearance to a capillary malformation  (
         <a class="graphic graphic_picture graphicRef89391" href="/z/d/graphic/89391.html" rel="external">
          picture 8
         </a>
         ). Hemangiomas with this presentation often have surrounding pallor representing vasoconstriction, which can help to differentiate them from capillary malformations early on. However, in contrast with capillary malformations, hemangiomas quickly begin to develop small vascular blebs and become raised  (
         <a class="graphic graphic_picture graphicRef65721" href="/z/d/graphic/65721.html" rel="external">
          picture 9
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/5794.html" rel="external">
          "Infantile hemangiomas: Epidemiology, pathogenesis, clinical features, and complications"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Arteriovenous malformation
         </strong>
         – Arteriovenous malformations may present as macular vascular birthmarks  (
         <a class="graphic graphic_picture graphicRef83553" href="/z/d/graphic/83553.html" rel="external">
          picture 10C
         </a>
         ). However, they are often warm to the touch, and a thrill may be felt on palpation. A distinguishing feature on dermoscopy may be reticular pigmentation with reticular vessels seen in arteriovenous malformations but not in capillary malformations [
         <a href="#rid35">
          35
         </a>
         ]. Over time, arteriovenous malformations become progressively raised and develop a deep component  (
         <a class="graphic graphic_picture graphicRef83576 graphicRef83577" href="/z/d/graphic/83576.html" rel="external">
          picture 10A-B
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/15122.html" rel="external">
          "Arteriovenous malformations of the extremities"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Linear scleroderma
         </strong>
         – Linear scleroderma (morphea) of the face, particularly the "en coup de sabre" form, may rarely present at birth as an erythematous patch and mimic a capillary malformation  (
         <a class="graphic graphic_picture graphicRef83578" href="/z/d/graphic/83578.html" rel="external">
          picture 11A
         </a>
         ) [
         <a href="#rid36">
          36,37
         </a>
         ]. Over time, these lesions develop induration and atrophy typical of scleroderma  (
         <a class="graphic graphic_picture graphicRef83579" href="/z/d/graphic/83579.html" rel="external">
          picture 11B
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/6399.html" rel="external">
          "Juvenile localized scleroderma"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H89686922">
         <span class="h1">
          INDICATIONS FOR REFERRAL
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neonates presenting with a capillary malformation involving the upper and lower eyelids and the frontotemporal region (V1 and V2 segments) should be referred for ophthalmologic examination to rule out glaucoma. (See
         <a class="local">
          'Glaucoma'
         </a>
         above.)
        </p>
        <p>
         Children with a facial capillary malformation and neurologic symptoms, particularly seizures, should be referred for neurologic examination and neuroimaging studies to exclude Sturge-Weber syndrome. (See
         <a class="medical medical_review" href="/z/d/html/6159.html" rel="external">
          "Sturge-Weber syndrome", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H89686929">
         <span class="h1">
          TREATMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Capillary malformations may be disfiguring and a source of significant psychologic stress for patients [
         <a href="#rid38">
          38
         </a>
         ]. The goals of treatment are cosmetic improvement (reduction of skin redness) and prevention of complications (eg, thickening, nodularity, or bleeding) [
         <a href="#rid39">
          39-42
         </a>
         ].
        </p>
        <p>
         Pulsed dye laser (PDL) therapy is considered the standard of care for the treatment of capillary malformations [
         <a href="#rid43">
          43
         </a>
         ]. It is based on the concept of selective photothermolysis with oxyhemoglobin as the target [
         <a href="#rid44">
          44
         </a>
         ]. PDL treatment irreversibly damages the capillary vessel wall with minimal damage to the overlying epidermis, which leads to lightening of the port wine birthmark without scarring [
         <a href="#rid45">
          45
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/13638.html" rel="external">
          "Laser and light therapy for cutaneous vascular lesions", section on 'Capillary malformations (port wine birthmarks)'
         </a>
         .)
        </p>
        <p>
         Lesions may recur after treatment. In a 10-year follow-up study of 51 patients treated with PDL for port wine birthmarks, lesions were significantly darker at follow-up than at the time of the last treatment [
         <a href="#rid46">
          46
         </a>
         ]. However, treated lesions remained significantly lighter than they were prior to the start of treatment, supporting the existence of long-lasting, beneficial effects of treatment.
        </p>
        <p>
         The efficacy of PDL is supported by several uncontrolled studies:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a retrospective study of 197 patients, the mean age at time of first treatment was 3.4 months [
         <a href="#rid47">
          47
         </a>
         ]. After an average of 9.8 treatments, 26 percent achieved 100 percent clearance, and an additional 41 percent achieved 76 to 99 percent clearance. None of the patients experienced permanent pigment change or scarring. Of note, all patients were treated without topical or general anesthesia.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a retrospective study of 49 infants ≤6 months of age, treatment with a 595 nm PDL with dynamic cooling led to an average percentage of lesion clearance of 89 percent. No patients developed atrophy or scarring [
         <a href="#rid48">
          48
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a prospective study of 12 children ages 6 to 30 weeks treated with PDL, 10 had greater than 50 percent lightening of port wine birthmarks after 2.9±1.4 treatments [
         <a href="#rid49">
          49
         </a>
         ]. No patients experienced scarring, atrophy, or dyspigmentation.
        </p>
        <p>
        </p>
        <p>
         PDL therapy for capillary malformations is reviewed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/13638.html" rel="external">
          "Laser and light therapy for cutaneous vascular lesions", section on 'Capillary malformations (port wine birthmarks)'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3700607">
         <span class="h1">
          ASSOCIATED SYNDROMES
         </span>
        </p>
        <p class="headingAnchor" id="H3700614">
         <span class="h2">
          Sturge-Weber syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Sturge-Weber syndrome (SWS) is a rare congenital disorder characterized by the classic triad of facial port wine birthmark, leptomeningeal angiomatosis, and ocular involvement. The capillary malformation associated with SWS usually occurs in the distribution area of the ophthalmic and/or maxillary branch (segments V1/V2) of the trigeminal nerve  (
         <a class="graphic graphic_figure graphicRef52850" href="/z/d/graphic/52850.html" rel="external">
          figure 1
         </a>
         ), involves both the upper and lower eyelids, and is often bilateral [
         <a href="#rid50">
          50
         </a>
         ]. The discovery of the somatic mutation in
         <em>
          GNAQ
         </em>
         associated with SWS has raised the hypothesis of somatic mosaicism in SWS [
         <a href="#rid8">
          8
         </a>
         ]. In a multicenter prospective study of 66 infants with upper facial port wine birthmarks larger than 1 cm
         <sup>
          2
         </sup>
         located in the ophthalmic division  (
         <a class="graphic graphic_figure graphicRef52850" href="/z/d/graphic/52850.html" rel="external">
          figure 1
         </a>
         ) of trigeminal nerve distribution, 11 (17 percent) were diagnosed with SWS [
         <a href="#rid12">
          12
         </a>
         ]. Hemifacial and median (including median linear) distribution pattern were associated with a high risk of SWS.
        </p>
        <p>
         Mutations in
         <em>
          GNA11
         </em>
         have also been reported in several cases of SWS with distinct characteristics [
         <a href="#rid51">
          51,52
         </a>
         ]. These patients have the typical, large, facial capillary malformation and glaucoma but have less severe neurologic symptoms. A distinguishing feature in this phenotype is diffuse, reticulated capillary malformations of the trunk and limbs with associated hyper- or hypotrophy.
        </p>
        <p>
         The clinical features, diagnosis, and treatment of SWS are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/6159.html" rel="external">
          "Sturge-Weber syndrome"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3700621">
         <span class="h2">
          Klippel-Trenaunay syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Klippel-Trenaunay syndrome (KTS) is characterized by capillary malformations, venous and lymphatic malformations, and soft tissue and bone hypertrophy involving a limb [
         <a href="#rid53">
          53,54
         </a>
         ]. The lower limbs, sometimes with extension to the trunk, are more frequently involved than the upper limbs.
        </p>
        <p>
         The capillary malformations are present at birth as extensive, geographic patches located on the trunk or extremity  (
         <a class="graphic graphic_picture graphicRef108288" href="/z/d/graphic/108288.html" rel="external">
          picture 12
         </a>
         ). Limb hypertrophy, resulting from soft tissue and bone overgrowth and underlying lymphatic abnormalities, may be apparent at birth or may develop later and progress until the end of puberty  (
         <a class="graphic graphic_picture graphicRef108290" href="/z/d/graphic/108290.html" rel="external">
          picture 13
         </a>
         ). KTS is caused by somatic mutations in the
         <em>
          PIK3CA
         </em>
         gene [
         <a href="#rid55">
          55
         </a>
         ].
        </p>
        <p>
         The pathogenesis, diagnosis, and management of KTS are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/13730.html" rel="external">
          "Klippel-Trenaunay syndrome: Clinical manifestations, diagnosis, and management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3700628">
         <span class="h2">
          Parkes Weber syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Parkes Weber syndrome is characterized by a large capillary malformation on an extremity; soft tissue and bone hypertrophy of the affected limb; and multiple microscopic, fast-flow arteriovenous shunts. The capillary malformation of Parkes Weber syndrome is indistinguishable from the port wine birthmark seen in KTS. Ultrasonography, MRI, and magnetic resonance arteriography are helpful in differentiating Parkes Weber syndrome from KTS. Parkes Weber syndrome has been associated with germline and somatic variants in
         <em>
          RASA1
         </em>
         [
         <a href="#rid56">
          56,57
         </a>
         ] and, in a minority of cases, with germline variants in
         <em>
          EPHB4
         </em>
         [
         <a href="#rid58">
          58
         </a>
         ].
        </p>
        <p>
         Patients with Parkes Weber syndrome have progressive overgrowth of the affected limb and complications related to the arteriovenous shunts, including ulcerations and high-output cardiac failure, especially in the neonatal period. (See
         <a class="medical medical_review" href="/z/d/html/13730.html" rel="external">
          "Klippel-Trenaunay syndrome: Clinical manifestations, diagnosis, and management", section on 'Parkes Weber syndrome'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3700635">
         <span class="h2">
          Servelle-Martorell syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Servelle-Martorell syndrome is a rare congenital angiodysplastic disease [
         <a href="#rid59">
          59
         </a>
         ]. It manifests with capillary malformations and varicosities similar to KTS but is associated with progressive limb hypotrophy rather than overgrowth.
        </p>
        <p class="headingAnchor" id="H3700642">
         <span class="h2">
          Proteus syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Proteus syndrome is an extremely rare disorder characterized by asymmetric and disproportionate overgrowth of body parts  (
         <a class="graphic graphic_picture graphicRef83559" href="/z/d/graphic/83559.html" rel="external">
          picture 14
         </a>
         ) [
         <a href="#rid60">
          60
         </a>
         ]. Mosaicism for a somatic activating mutation in the
         <em>
          AKT1
         </em>
         oncogene is thought to be the cause of Proteus syndrome.
        </p>
        <p>
         Cutaneous findings are present in approximately 40 percent of neonates and include capillary, lymphatic, or venous malformations; linear and nonlinear epidermal nevi; cerebriform connective tissue nevi; lipomatous tissue overgrowth or lipoatrophy; café-au-lait macules; and nail abnormalities [
         <a href="#rid61">
          61
         </a>
         ]. The vascular malformations are usually extensive, covering a large portion of the body, and may be associated with visceral vascular malformations. Cerebriform epidermal nevi occur predominantly on soles and palms  (
         <a class="graphic graphic_picture graphicRef73826" href="/z/d/graphic/73826.html" rel="external">
          picture 15
         </a>
         ). Overgrowth is evident at birth in approximately 20 percent of cases and is asymmetric, disproportionate, and progressive. It may involve many tissues including bone, cartilage, muscle, and connective tissue.
        </p>
        <p class="headingAnchor" id="H36298824">
         <span class="h2">
          CLOVES syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         CLOVES (congenital lipomatous overgrowth, vascular malformations, epidermal nevi, spinal/skeletal anomalies/scoliosis) syndrome is a very rare congenital disorder caused by somatic mosaic activating mutations in the
         <em>
          PIK3CA
         </em>
         gene [
         <a href="#rid62">
          62-64
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/13730.html" rel="external">
          "Klippel-Trenaunay syndrome: Clinical manifestations, diagnosis, and management", section on 'CLOVES syndrome'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3700649">
         <span class="h2">
          Bannayan-Riley-Ruvalcaba syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bannayan-Riley-Ruvalcaba syndrome, which is incorporated into Cowden syndrome-1 (MIM #158350), is an autosomal dominant disorder caused by mutations in the tumor suppressor gene
         <em>
          PTEN
         </em>
         [
         <a href="#rid65">
          65
         </a>
         ]. Cutaneous features include capillary, venous, and lymphatic malformations as well as lipomas and pigmented macules on the genitalia. Associated findings include macrocephaly, pseudopapilledema, intellectual disability, and juvenile intestinal polyposis.
        </p>
        <p>
         Cowden syndrome-1 is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/16543.html" rel="external">
          "PTEN hamartoma tumor syndromes, including Cowden syndrome", section on 'Bannayan-Riley-Ruvalcaba syndrome'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3700656">
         <span class="h2">
          Capillary malformation-arteriovenous malformation syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Capillary malformation-arteriovenous malformation (CM-AVM) syndrome is an autosomal dominant disorder characterized by atypical, cutaneous capillary malformations in conjunction with an arteriovenous malformation. It is caused by pathogenic variants in the
         <em>
          RASA1
         </em>
         gene (CM-AVM1; MIM #608354) or in the
         <em>
          EPHB4
         </em>
         gene
         <em>
         </em>
         (CM-AVM2; MIM #618196) [
         <a href="#rid9">
          9,58
         </a>
         ].
         <em>
          RASA1
         </em>
         encodes a guanine nucleotide-binding protein (p21) involved in the control of cell proliferation and differentiation and organization of endothelial cells into highly organized networks [
         <a href="#rid10">
          10
         </a>
         ].
         <em>
          EPHB4
         </em>
         encodes the ephrin receptor EphB4, a transmembrane tyrosine kinase.
        </p>
        <p>
         Capillary malformations occur in nearly 100 percent of patients with either CM-AVM1 or CM-AVM2. They are usually multiple round to oval, pink-red or tan patches of 1 to 2 cm in size, sometimes with a pale halo, scattered randomly on the body (predominantly on the face and limbs). New lesions may continue to appear throughout childhood.
        </p>
        <p>
         Fast-flow arteriovenous malformations have been reported in approximately 30 and 20 percent of patients with CM-AVM1 and CM-AVM2, respectively [
         <a href="#rid58">
          58,66
         </a>
         ]. They can be located in the soft tissues, muscles, bones, brain, or spine [
         <a href="#rid67">
          67,68
         </a>
         ]. Arteriovenous malformations in the central nervous system are more common in CM-AVM1 than in CM-AVM2 (10 versus 3 percent, respectively). Of note, vein of Galen aneurysmal malformations have been reported in CM-AVM2 [
         <a href="#rid58">
          58
         </a>
         ].
        </p>
        <p>
         Approximately 8 percent of patients have a Parkes Weber syndrome phenotype (see
         <a class="local">
          'Parkes Weber syndrome'
         </a>
         above). Other clinical findings include telangiectasias, lymphatic malformations, and cardiac failure due to volume overload [
         <a href="#rid66">
          66
         </a>
         ].
        </p>
        <p>
         In patients with clinical findings that suggest CM-AVM syndrome, genetic testing for a heterozygous pathogenic variant in
         <em>
          RASA1
         </em>
         or
         <em>
          EPHB4
         </em>
         is necessary to confirm the diagnosis.
        </p>
        <p class="headingAnchor" id="H3700663">
         <span class="h2">
          Macrocephaly-capillary malformation syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Macrocephaly-capillary malformation (M-CM) syndrome (previously named macrocephaly-cutis marmorata telangiectatica congenita) is a genetic syndrome characterized by an enlarged head circumference and patchy, reticular capillary malformations [
         <a href="#rid69">
          69-71
         </a>
         ]. It is caused by mutations in the
         <em>
          PIK3CA
         </em>
         gene, leading to gain of function and activation of the PI3K-AKT pathway, which is involved in cell growth, proliferation, survival, and apoptosis [
         <a href="#rid72">
          72,73
         </a>
         ].
        </p>
        <p>
         The diagnosis is based upon the presence of two major clinical criteria and at least two minor criteria.
        </p>
        <p>
         Major criteria are:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Macrocephaly
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Capillary malformation
        </p>
        <p>
        </p>
        <p>
         Minor criteria are:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Asymmetry or overgrowth
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Developmental delay
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hypotonia
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Syndactyly or polydactyly
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Frontal bossing
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hydrocephalus
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Connective tissue abnormalities such as joint hypermobility or hyperelastic skin
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Midline facial nevus simplex
        </p>
        <p>
        </p>
        <p>
         The capillary malformations are usually reticulated and widespread on the trunk and extremities. Cardiac abnormalities including aortic coarctation have also been described [
         <a href="#rid74">
          74,75
         </a>
         ]. Neuroimaging findings include white matter abnormalities, ventriculomegaly, cerebral asymmetry, cortical dysplasia, polymicrogyria-like changes, and cerebellar tonsil herniation [
         <a href="#rid76">
          76
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H809583">
         <span class="h2">
          Microcephaly-capillary malformation syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Microcephaly-capillary malformation (MIM #614261) is an autosomal recessive syndrome due to mutations in the
         <em>
          STAMBP
         </em>
         gene on chromosome 2p13.1, encoding a deubiquitinating enzyme [
         <a href="#rid77">
          77-80
         </a>
         ]. It presents with:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Severe progressive microcephaly
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diffuse small capillary malformations of the skin
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Profound global developmental delay
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Severe spastic quadriparesis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Neonatal-onset intractable epilepsy
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hypoplastic distal phalanges
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Poor growth
        </p>
        <p>
        </p>
        <p>
         The capillary malformations range in size from 2 to 15 mm and are scattered on the trunk, extremities, and head. Minor heart malformations, including small atrial and ventricular septal defects, have also been reported [
         <a href="#rid78">
          78
         </a>
         ]. Neuroimaging findings include diffusely reduced number of gyri with shallow sulci consistent with a severe simplified gyral pattern, and moderately enlarged extra-axial space [
         <a href="#rid78">
          78
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3700670">
         <span class="h2">
          Beckwith-Wiedemann syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Beckwith-Wiedemann syndrome is a congenital overgrowth syndrome with major features including anterior abdominal wall defects, macroglossia, gigantism, and a propensity to develop specific tumors (hepatoblastoma, Wilms tumour, neuroblastoma, and rhabdomyosarcoma) [
         <a href="#rid81">
          81,82
         </a>
         ]. Infants have centrofacial capillary malformations similar to nevus simplex in the majority of cases. Vascular lesions may extend to the upper eyelids, upper lip, and nose. Characteristic-associated findings are an anterior ear lobe crease and posterior helical ear pits.
        </p>
        <p>
         Beckwith-Wiedemann syndrome is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/13555.html" rel="external">
          "Beckwith-Wiedemann syndrome"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3700677">
         <span class="h2">
          Phakomatosis pigmentovascularis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Phakomatosis pigmentovascularis is a syndrome associated with mosaic activating variants of the
         <em>
          GNA11
         </em>
         and
         <em>
          GNAQ
         </em>
         genes and is characterized by the association of a widespread capillary malformation with pigmented lesions including dermal melanocytosis, nevus spilus, mosaic hyperpigmentation, and epidermal nevus [
         <a href="#rid83">
          83
         </a>
         ]. Nevus anemicus and café-au-lait spots can be associated findings. Extracutaneous findings include visceral, muscular, neurologic, or ocular abnormalities.
        </p>
        <p>
         Five types of phakomatosis pigmentovascularis have been identified based upon the type of pigmented lesion associated with the capillary malformation; for each type, subtype "a" denotes absence and subtype "b" presence of extracutaneous findings  (
         <a class="graphic graphic_table graphicRef83711" href="/z/d/graphic/83711.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid84">
          84-86
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5789.html" rel="external">
          "Vascular lesions in the newborn", section on 'Phakomatosis pigmentovascularis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2510243979">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/122193.html" rel="external">
          "Society guideline links: Vascular anomalies"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H14531711">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation
         </strong>
         – Capillary malformations (port wine birthmarks or nevus flammeus) are low-flow vascular malformations of dermal capillaries and postcapillary venules that are present at birth. Characteristic clinical features include blanchable, pink to red patches located anywhere on the body  (
         <a class="graphic graphic_picture graphicRef54078" href="/z/d/graphic/54078.html" rel="external">
          picture 1
         </a>
         ), typically with a unilateral or segmental distribution that respects the midline  (
         <a class="graphic graphic_picture graphicRef83601 graphicRef59124 graphicRef73978" href="/z/d/graphic/83601.html" rel="external">
          picture 5A-C
         </a>
         ). On the face, capillary malformations tend to follow the distribution of the trigeminal nerve branches  (
         <a class="graphic graphic_picture graphicRef73978" href="/z/d/graphic/73978.html" rel="external">
          picture 5C
         </a>
         and
         <a class="graphic graphic_figure graphicRef52850" href="/z/d/graphic/52850.html" rel="external">
          figure 1
         </a>
         ). (See
         <a class="local">
          'Clinical presentation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical course
         </strong>
         – Lesions
         <strong>
          do not
         </strong>
         regress spontaneously and, if left untreated, may become thicker, darker in color (port wine), and nodular in adulthood  (
         <a class="graphic graphic_picture graphicRef58831" href="/z/d/graphic/58831.html" rel="external">
          picture 3
         </a>
         ). (See
         <a class="local">
          'Clinical course'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – The diagnosis of capillary malformations can be made with a history and examination in patients with characteristic clinical features  (
         <a class="graphic graphic_picture graphicRef83601 graphicRef59124 graphicRef73978" href="/z/d/graphic/83601.html" rel="external">
          picture 5A-C
         </a>
         ). Imaging studies (ultrasonography or magnetic resonance) may be necessary in the evaluation of associated syndromes or abnormalities. (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Differential diagnosis
         </strong>
         – The differential diagnosis of capillary malformations includes nevus simplex (salmon patch or stork bite)  (
         <a class="graphic graphic_picture graphicRef83580" href="/z/d/graphic/83580.html" rel="external">
          picture 7
         </a>
         ), infantile hemangioma  (
         <a class="graphic graphic_picture graphicRef65721" href="/z/d/graphic/65721.html" rel="external">
          picture 9
         </a>
         ), arteriovenous malformation  (
         <a class="graphic graphic_picture graphicRef83553 graphicRef83576 graphicRef83577" href="/z/d/graphic/83553.html" rel="external">
          picture 10A-C
         </a>
         ), and linear scleroderma  (
         <a class="graphic graphic_picture graphicRef83578 graphicRef83579" href="/z/d/graphic/83578.html" rel="external">
          picture 11A-B
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment
         </strong>
         – For children and young patients with capillary malformations who desire treatment, we suggest treatment with pulsed dye laser (PDL) over other lasers as first-line treatment (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). PDL therapy for capillary malformations is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/13638.html" rel="external">
          "Laser and light therapy for cutaneous vascular lesions", section on 'Capillary malformations (port wine birthmarks)'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Associated syndromes
         </strong>
         – In most cases, capillary malformations are isolated cutaneous anomalies. However, they may be associated with other abnormalities (eg, glaucoma and occult spinal dysraphism) or be a component of complex malformation syndromes (eg, Sturge-Weber or Klippel Trenaunay syndrome). (See
         <a class="local">
          'Associated abnormalities/complications'
         </a>
         above and
         <a class="local">
          'Associated syndromes'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Kanada KN, Merin MR, Munden A, Friedlander SF. A prospective study of cutaneous findings in newborns in the United States: correlation with race, ethnicity, and gestational status using updated classification and nomenclature. J Pediatr 2012; 161:240.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hershkovitz D, Bercovich D, Sprecher E, Lapidot M. RASA1 mutations may cause hereditary capillary malformations without arteriovenous malformations. Br J Dermatol 2008; 158:1035.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eerola I, Boon LM, Watanabe S, et al. Locus for susceptibility for familial capillary malformation ('port-wine stain') maps to 5q. Eur J Hum Genet 2002; 10:375.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Breugem CC, Alders M, Salieb-Beugelaar GB, et al. A locus for hereditary capillary malformations mapped on chromosome 5q. Hum Genet 2002; 110:343.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smoller BR, Rosen S. Port-wine stains. A disease of altered neural modulation of blood vessels? Arch Dermatol 1986; 122:177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vural E, Ramakrishnan J, Cetin N, et al. The expression of vascular endothelial growth factor and its receptors in port-wine stains. Otolaryngol Head Neck Surg 2008; 139:560.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parsa CF. Sturge-weber syndrome: a unified pathophysiologic mechanism. Curr Treat Options Neurol 2008; 10:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shirley MD, Tang H, Gallione CJ, et al. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med 2013; 368:1971.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eerola I, Boon LM, Mulliken JB, et al. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet 2003; 73:1240.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Henkemeyer M, Rossi DJ, Holmyard DP, et al. Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein. Nature 1995; 377:695.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang CJ, Yu JS, Nelson JS. Confocal microscopy study of neurovascular distribution in facial port wine stains (capillary malformation). J Formos Med Assoc 2008; 107:559.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dutkiewicz AS, Ezzedine K, Mazereeuw-Hautier J, et al. A prospective study of risk for Sturge-Weber syndrome in children with upper facial port-wine stain. J Am Acad Dermatol 2015; 72:473.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Waelchli R, Aylett SE, Robinson K, et al. New vascular classification of port-wine stains: improving prediction of Sturge-Weber risk. Br J Dermatol 2014; 171:861.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khaier A, Nischal KK, Espinosa M, Manoj B. Periocular port wine stain: the great ormond street hospital experience. Ophthalmology 2011; 118:2274.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sharan S, Swamy B, Taranath DA, et al. Port-wine vascular malformations and glaucoma risk in Sturge-Weber syndrome. J AAPOS 2009; 13:374.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hennedige AA, Quaba AA, Al-Nakib K. Sturge-Weber syndrome and dermatomal facial port-wine stains: incidence, association with glaucoma, and pulsed tunable dye laser treatment effectiveness. Plast Reconstr Surg 2008; 121:1173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ch'ng S, Tan ST. Facial port-wine stains - clinical stratification and risks of neuro-ocular involvement. J Plast Reconstr Aesthet Surg 2008; 61:889.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guggisberg D, Hadj-Rabia S, Viney C, et al. Skin markers of occult spinal dysraphism in children: a review of 54 cases. Arch Dermatol 2004; 140:1109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ben-Amitai D, Davidson S, Schwartz M, et al. Sacral nevus flammeus simplex: the role of imaging. Pediatr Dermatol 2000; 17:469.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Metzker A, Shamir R. Butterfly-shaped mark: a variant form of nevus flammeus simplex. Pediatrics 1990; 85:1069.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patrizi A, Neri I, Orlandi C, Marini R. Sacral medial telangiectatic vascular nevus: a study of 43 children. Dermatology 1996; 192:301.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dowling MB, Zhao Y, Darrow DH. Orodental manifestations of facial port-wine stains. J Am Acad Dermatol 2012; 67:687.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garzon MC, Huang JT, Enjolras O, Frieden IJ. Vascular malformations: Part I. J Am Acad Dermatol 2007; 56:353.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mills CM, Lanigan SW, Hughes J, Anstey AV. Demographic study of port wine stain patients attending a laser clinic: family history, prevalence of naevus anaemicus and results of prior treatment. Clin Exp Dermatol 1997; 22:166.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geronemus RG, Ashinoff R. The medical necessity of evaluation and treatment of port-wine stains. J Dermatol Surg Oncol 1991; 17:76.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klapman MH, Yao JF. Thickening and nodules in port-wine stains. J Am Acad Dermatol 2001; 44:300.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim TH, Choi EH, Ahn SK, Lee SH. Vascular tumors arising in port-wine stains: two cases of pyogenic granuloma and a case of acquired tufted angioma. J Dermatol 1999; 26:813.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Swerlick RA, Cooper PH. Pyogenic granuloma (lobular capillary hemangioma) within port-wine stains. J Am Acad Dermatol 1983; 8:627.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu S, Yang C, Xu S, et al. Pyogenic granuloma arising as a complication of 595 nm tunable pulsed dye laser treatment of port-wine stains: report of four cases. Dermatol Surg 2010; 36:1341.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen D, Hu XJ, Lin XX, et al. Nodules arising within port-wine stains: a clinicopathologic study of 31 cases. Am J Dermatopathol 2011; 33:144.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alessi E, Bertani E, Sala F. Acquired tufted angioma. Am J Dermatopathol 1986; 8:426.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Piram M, Lorette G, Sirinelli D, et al. Sturge-Weber syndrome in patients with facial port-wine stain. Pediatr Dermatol 2012; 29:32.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mazereeuw-Hautier J, Syed S, Harper JI. Bilateral facial capillary malformation associated with eye and brain abnormalities. Arch Dermatol 2006; 142:994.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Juern AM, Glick ZR, Drolet BA, Frieden IJ. Nevus simplex: a reconsideration of nomenclature, sites of involvement, and disease associations. J Am Acad Dermatol 2010; 63:805.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sun Y, Su L, Zhang Y, et al. Dermatoscopic features differentiating among port wine stain, arteriovenous malformation, and capillary malformation-arteriovenous malformation syndrome: to detect potential fast-flow vascular malformations at an early stage. J Am Acad Dermatol 2022; 87:1435.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nijhawan RI, Bard S, Blyumin M, et al. Early localized morphea mimicking an acquired port-wine stain. J Am Acad Dermatol 2011; 64:779.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zulian F, Vallongo C, de Oliveira SK, et al. Congenital localized scleroderma. J Pediatr 2006; 149:248.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lanigan SW, Cotterill JA. Psychological disabilities amongst patients with port wine stains. Br J Dermatol 1989; 121:209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McClean K, Hanke CW. The medical necessity for treatment of port-wine stains. Dermatol Surg 1997; 23:663.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wagner KD, Wagner RF Jr. The necessity for treatment of childhood port-wine stains. Cutis 1990; 45:317.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strauss RP, Resnick SD. Pulsed dye laser therapy for port-wine stains in children: psychosocial and ethical issues. J Pediatr 1993; 122:505.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hansen K, Kreiter CD, Rosenbaum M, et al. Long-term psychological impact and perceived efficacy of pulsed-dye laser therapy for patients with port-wine stains. Dermatol Surg 2003; 29:49.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Faurschou A, Olesen AB, Leonardi-Bee J, Haedersdal M. Lasers or light sources for treating port-wine stains. Cochrane Database Syst Rev 2011; :CD007152.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 1983; 220:524.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jasim ZF, Handley JM. Treatment of pulsed dye laser-resistant port wine stain birthmarks. J Am Acad Dermatol 2007; 57:677.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huikeshoven M, Koster PH, de Borgie CA, et al. Redarkening of port-wine stains 10 years after pulsed-dye-laser treatment. N Engl J Med 2007; 356:1235.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jeon H, Bernstein LJ, Belkin DA, et al. Pulsed Dye Laser Treatment of Port-Wine Stains in Infancy Without the Need for General Anesthesia. JAMA Dermatol 2019; 155:435.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chapas AM, Eickhorst K, Geronemus RG. Efficacy of early treatment of facial port wine stains in newborns: a review of 49 cases. Lasers Surg Med 2007; 39:563.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ashinoff R, Geronemus RG. Flashlamp-pumped pulsed dye laser for port-wine stains in infancy: earlier versus later treatment. J Am Acad Dermatol 1991; 24:467.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tallman B, Tan OT, Morelli JG, et al. Location of port-wine stains and the likelihood of ophthalmic and/or central nervous system complications. Pediatrics 1991; 87:323.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thorpe J, Frelin LP, McCann M, et al. Identification of a Mosaic Activating Mutation in GNA11 in Atypical Sturge-Weber Syndrome. J Invest Dermatol 2021; 141:685.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dompmartin A, van der Vleuten CJM, Dekeuleneer V, et al. GNA11-mutated Sturge-Weber syndrome has distinct neurological and dermatological features. Eur J Neurol 2022; 29:3061.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garzon MC, Huang JT, Enjolras O, Frieden IJ. Vascular malformations. Part II: associated syndromes. J Am Acad Dermatol 2007; 56:541.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wassef M, Blei F, Adams D, et al. Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies. Pediatrics 2015; 136:e203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Luks VL, Kamitaki N, Vivero MP, et al. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA. J Pediatr 2015; 166:1048.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Revencu N, Boon LM, Mulliken JB, et al. Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Hum Mutat 2008; 29:959.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Flores Daboub JA, Grimmer JF, Frigerio A, et al. Parkes Weber syndrome associated with two somatic pathogenic variants in RASA1. Cold Spring Harb Mol Case Stud 2020; 6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amyere M, Revencu N, Helaers R, et al. Germline Loss-of-Function Mutations in EPHB4 Cause a Second Form of Capillary Malformation-Arteriovenous Malformation (CM-AVM2) Deregulating RAS-MAPK Signaling. Circulation 2017; 136:1037.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marsden N, Shokrollahi K, Maw K, et al. Congenital vascular malformation associated with multiple cranial, vertebral and upper limb skeletal abnormalities. Ann R Coll Surg Engl 2010; 92:W18.
          </a>
         </li>
         <li class="breakAll">
          Biesecker LG, Sapp JC. Proteus syndrome. In: GeneReviews, Adam MP, Everman DB, Mirzaa GM, et al (Eds), University of Washington, Seattle, Seattle (WA) 1993.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pithadia DJ, Cartron AM, Biesecker LG, Darling TN. Dermatologic findings in individuals with genetically confirmed Proteus syndrome. Pediatr Dermatol 2021; 38:794.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sapp JC, Turner JT, van de Kamp JM, et al. Newly delineated syndrome of congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE syndrome) in seven patients. Am J Med Genet A 2007; 143A:2944.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alomari AI. Characterization of a distinct syndrome that associates complex truncal overgrowth, vascular, and acral anomalies: a descriptive study of 18 cases of CLOVES syndrome. Clin Dysmorphol 2009; 18:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kurek KC, Luks VL, Ayturk UM, et al. Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome. Am J Hum Genet 2012; 90:1108.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marsh DJ, Dahia PL, Zheng Z, et al. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet 1997; 16:333.
          </a>
         </li>
         <li class="breakAll">
          Bayrak-Toydemir P, Stevenson DA. Capillary malformation-arteriovenous malformation syndrome. In: GeneReviews, Adam MP, Ardinger HH, Pagon RA, et al (Eds), University of Washington, Seattle, 1993.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thiex R, Mulliken JB, Revencu N, et al. A novel association between RASA1 mutations and spinal arteriovenous anomalies. AJNR Am J Neuroradiol 2010; 31:775.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Revencu N, Boon LM, Mendola A, et al. RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation. Hum Mutat 2013; 34:1632.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wright DR, Frieden IJ, Orlow SJ, et al. The misnomer "macrocephaly-cutis marmorata telangiectatica congenita syndrome": report of 12 new cases and support for revising the name to macrocephaly-capillary malformations. Arch Dermatol 2009; 145:287.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martínez-Glez V, Romanelli V, Mori MA, et al. Macrocephaly-capillary malformation: Analysis of 13 patients and review of the diagnostic criteria. Am J Med Genet A 2010; 152A:3101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Toriello HV, Mulliken JB. Accurately renaming macrocephaly-cutis marmorata telangiectatica congenita (M-CMTC) as macrocephaly-capillary malformation (M-CM). Am J Med Genet A 2007; 143A:3009.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rivière JB, Mirzaa GM, O'Roak BJ, et al. De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat Genet 2012; 44:934.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mirzaa GM, Rivière JB, Dobyns WB. Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP. Am J Med Genet C Semin Med Genet 2013; 163C:122.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lapunzina P, Gairí A, Delicado A, et al. Macrocephaly-cutis marmorata telangiectatica congenita: report of six new patients and a review. Am J Med Genet A 2004; 130A:45.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gonzalez ME, Burk CJ, Barbouth DS, Connelly EA. Macrocephaly-capillary malformation: a report of three cases and review of the literature. Pediatr Dermatol 2009; 26:342.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Conway RL, Pressman BD, Dobyns WB, et al. Neuroimaging findings in macrocephaly-capillary malformation: a longitudinal study of 17 patients. Am J Med Genet A 2007; 143A:2981.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McDonell LM, Mirzaa GM, Alcantara D, et al. Mutations in STAMBP, encoding a deubiquitinating enzyme, cause microcephaly-capillary malformation syndrome. Nat Genet 2013; 45:556.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mirzaa GM, Paciorkowski AR, Smyser CD, et al. The microcephaly-capillary malformation syndrome. Am J Med Genet A 2011; 155A:2080.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Isidor B, Barbarot S, Bénéteau C, et al. Multiple capillary skin malformations, epilepsy, microcephaly, mental retardation, hypoplasia of the distal phalanges: report of a new case and further delineation of a new syndrome. Am J Med Genet A 2011; 155A:1458.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carter MT, Geraghty MT, De La Cruz L, et al. A new syndrome with multiple capillary malformations, intractable seizures, and brain and limb anomalies. Am J Med Genet A 2011; 155A:301.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weksberg R, Shuman C, Beckwith JB. Beckwith-Wiedemann syndrome. Eur J Hum Genet 2010; 18:8.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DeBaun MR, Tucker MA. Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry. J Pediatr 1998; 132:398.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thomas AC, Zeng Z, Rivière JB, et al. Mosaic Activating Mutations in GNA11 and GNAQ Are Associated with Phakomatosis Pigmentovascularis and Extensive Dermal Melanocytosis. J Invest Dermatol 2016; 136:770.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernández-Guarino M, Boixeda P, de Las Heras E, et al. Phakomatosis pigmentovascularis: Clinical findings in 15 patients and review of the literature. J Am Acad Dermatol 2008; 58:88.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Torrelo A, Zambrano A, Happle R. Large aberrant Mongolian spots coexisting with cutis marmorata telangiectatica congenita (phacomatosis pigmentovascularis type V or phacomatosis cesiomarmorata). J Eur Acad Dermatol Venereol 2006; 20:308.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Happle R. Phacomatosis pigmentovascularis revisited and reclassified. Arch Dermatol 2005; 141:385.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 13726 Version 30.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22497908" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : A prospective study of cutaneous findings in newborns in the United States: correlation with race, ethnicity, and gestational status using updated classification and nomenclature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18363760" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : RASA1 mutations may cause hereditary capillary malformations without arteriovenous malformations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12080389" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Locus for susceptibility for familial capillary malformation ('port-wine stain') maps to 5q.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11941483" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : A locus for hereditary capillary malformations mapped on chromosome 5q.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3511859" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Port-wine stains. A disease of altered neural modulation of blood vessels?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18922344" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : The expression of vascular endothelial growth factor and its receptors in port-wine stains.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18325299" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Sturge-weber syndrome: a unified pathophysiologic mechanism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23656586" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14639529" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7477259" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18632415" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Confocal microscopy study of neurovascular distribution in facial port wine stains (capillary malformation).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25592619" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : A prospective study of risk for Sturge-Weber syndrome in children with upper facial port-wine stain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24976116" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : New vascular classification of port-wine stains: improving prediction of Sturge-Weber risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21783256" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Periocular port wine stain: the great ormond street hospital experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19683189" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Port-wine vascular malformations and glaucoma risk in Sturge-Weber syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18349634" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Sturge-Weber syndrome and dermatomal facial port-wine stains: incidence, association with glaucoma, and pulsed tunable dye laser treatment effectiveness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17604243" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Facial port-wine stains - clinical stratification and risks of neuro-ocular involvement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15381552" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Skin markers of occult spinal dysraphism in children: a review of 54 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11123782" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Sacral nevus flammeus simplex: the role of imaging.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2101578" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Butterfly-shaped mark: a variant form of nevus flammeus simplex.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8864361" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Sacral medial telangiectatic vascular nevus: a study of 43 children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22226814" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Orodental manifestations of facial port-wine stains.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17317485" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Vascular malformations: Part I.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9499604" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Demographic study of port wine stain patients attending a laser clinic: family history, prevalence of naevus anaemicus and results of prior treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1991884" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : The medical necessity of evaluation and treatment of port-wine stains.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11174392" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Thickening and nodules in port-wine stains.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10659503" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Vascular tumors arising in port-wine stains: two cases of pyogenic granuloma and a case of acquired tufted angioma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6863618" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Pyogenic granuloma (lobular capillary hemangioma) within port-wine stains.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20584041" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Pyogenic granuloma arising as a complication of 595 nm tunable pulsed dye laser treatment of port-wine stains: report of four cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20940617" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Nodules arising within port-wine stains: a clinicopathologic study of 31 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3777379" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Acquired tufted angioma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21906147" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Sturge-Weber syndrome in patients with facial port-wine stain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16924048" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Bilateral facial capillary malformation associated with eye and brain abnormalities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20728246" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Nevus simplex: a reconsideration of nomenclature, sites of involvement, and disease associations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35952834" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Dermatoscopic features differentiating among port wine stain, arteriovenous malformation, and capillary malformation-arteriovenous malformation syndrome: to detect potential fast-flow vascular malformations at an early stage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20850196" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Early localized morphea mimicking an acquired port-wine stain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16887444" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Congenital localized scleroderma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2775645" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Psychological disabilities amongst patients with port wine stains.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9256913" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : The medical necessity for treatment of port-wine stains.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2192830" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : The necessity for treatment of childhood port-wine stains.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8463892" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Pulsed dye laser therapy for port-wine stains in children: psychosocial and ethical issues.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12534512" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Long-term psychological impact and perceived efficacy of pulsed-dye laser therapy for patients with port-wine stains.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22071834" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Lasers or light sources for treating port-wine stains.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6836297" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17658196" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Treatment of pulsed dye laser-resistant port wine stain birthmarks.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17377161" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Redarkening of port-wine stains 10 years after pulsed-dye-laser treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30865245" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Pulsed Dye Laser Treatment of Port-Wine Stains in Infancy Without the Need for General Anesthesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17868100" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Efficacy of early treatment of facial port wine stains in newborns: a review of 49 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2061448" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Flashlamp-pumped pulsed dye laser for port-wine stains in infancy: earlier versus later treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1805804" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Location of port-wine stains and the likelihood of ophthalmic and/or central nervous system complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32771470" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Identification of a Mosaic Activating Mutation in GNA11 in Atypical Sturge-Weber Syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35715928" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : GNA11-mutated Sturge-Weber syndrome has distinct neurological and dermatological features.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17367610" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Vascular malformations. Part II: associated syndromes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26055853" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25681199" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18446851" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32843429" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Parkes Weber syndrome associated with two somatic pathogenic variants in RASA1.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28687708" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Germline Loss-of-Function Mutations in EPHB4 Cause a Second Form of Capillary Malformation-Arteriovenous Malformation (CM-AVM2) Deregulating RAS-MAPK Signaling.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20529464" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Congenital vascular malformation associated with multiple cranial, vertebral and upper limb skeletal abnormalities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20529464" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Congenital vascular malformation associated with multiple cranial, vertebral and upper limb skeletal abnormalities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34105192" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Dermatologic findings in individuals with genetically confirmed Proteus syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17963221" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Newly delineated syndrome of congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE syndrome) in seven patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19011570" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Characterization of a distinct syndrome that associates complex truncal overgrowth, vascular, and acral anomalies: a descriptive study of 18 cases of CLOVES syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22658544" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9241266" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Germline mutations in PTEN are present in Bannayan-Zonana syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9241266" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Germline mutations in PTEN are present in Bannayan-Zonana syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20007727" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : A novel association between RASA1 mutations and spinal arteriovenous anomalies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24038909" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19289759" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : The misnomer "macrocephaly-cutis marmorata telangiectatica congenita syndrome": report of 12 new cases and support for revising the name to macrocephaly-capillary malformations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21077203" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Macrocephaly-capillary malformation: Analysis of 13 patients and review of the diagnostic criteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17963258" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Accurately renaming macrocephaly-cutis marmorata telangiectatica congenita (M-CMTC) as macrocephaly-capillary malformation (M-CM).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22729224" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23592320" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15368495" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Macrocephaly-cutis marmorata telangiectatica congenita: report of six new patients and a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19706101" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Macrocephaly-capillary malformation: a report of three cases and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18000912" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Neuroimaging findings in macrocephaly-capillary malformation: a longitudinal study of 17 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23542699" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Mutations in STAMBP, encoding a deubiquitinating enzyme, cause microcephaly-capillary malformation syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21815250" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : The microcephaly-capillary malformation syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21548128" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Multiple capillary skin malformations, epilepsy, microcephaly, mental retardation, hypoplasia of the distal phalanges: report of a new case and further delineation of a new syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21271646" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : A new syndrome with multiple capillary malformations, intractable seizures, and brain and limb anomalies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19550435" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Beckwith-Wiedemann syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9544889" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26778290" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Mosaic Activating Mutations in GNA11 and GNAQ Are Associated with Phakomatosis Pigmentovascularis and Extensive Dermal Melanocytosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18045734" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Phakomatosis pigmentovascularis: Clinical findings in 15 patients and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16503893" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Large aberrant Mongolian spots coexisting with cutis marmorata telangiectatica congenita (phacomatosis pigmentovascularis type V or phacomatosis cesiomarmorata).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15781681" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Phacomatosis pigmentovascularis revisited and reclassified.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
